Ascent Wealth Partners’s Pfizer PFE Stock Holding History

Ascent Wealth Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.43M	Buy	86,553 +2,376	+3%	+$63.3K	0.28%	79
2025 Q4	$2.1M	Buy	84,177 +17,937	+27%	+$452K	0.24%	84
2025 Q3	$1.69M	Buy	66,240 +5,143	+8%	+$127K	0.2%	99
2025 Q2	$1.48M	Sell	61,097 -15,530	-20%	-$362K	0.18%	105
2025 Q1	$1.94M	Buy	76,627 +1,039	+1%	+$27.2K	0.26%	79
2024 Q4	$2.01M	Buy	75,588 +734	+1%	+$19.9K	0.27%	71
2024 Q3	$2.17M	Sell	74,854 -405	-0.5%	-$11.8K	0.3%	69
2024 Q2	$2.11M	Buy	75,259 +8,516	+13%	+$234K	0.31%	65
2024 Q1	$1.85M	Buy	66,743 +25,311	+61%	+$702K	0.28%	68
2023 Q4	$1.19M	Sell	41,432 -1,267	-3%	-$38.3K	0.19%	91
2023 Q3	$1.42M	Buy	42,699 +1,040	+2%	+$36.8K	0.26%	77
2023 Q2	$1.53M	Buy	41,659 +1,530	+4%	+$59.6K	0.27%	76
2023 Q1	$1.64M	Buy	40,129 +1,625	+4%	+$70.2K	0.33%	67
2022 Q4	$1.97M	Buy	38,504 +1,748	+5%	+$83.8K	0.42%	57
2022 Q3	$1.61M	Sell	36,756 -589	-2%	-$28.6K	0.38%	63
2022 Q2	$1.99M	Buy	37,345 +5,095	+16%	+$260K	0.45%	56
2022 Q1	$1.67M	Buy	32,250 +1,136	+4%	+$58.9K	0.31%	65
2021 Q4	$1.84M	Buy	31,114 +1,985	+7%	+$98.3K	0.33%	65
2021 Q3	$1.25M	Buy	29,129 +3,755	+15%	+$166K	0.24%	75
2021 Q2	$994K	Buy	25,374 +11,009	+77%	+$428K	0.19%	82
2021 Q1	$520K	Buy	14,365 +179	+1%	+$6.36K	0.11%	91
2020 Q4	$522K	Sell	14,186 -531	-4%	-$19.5K	0.12%	89
2020 Q3	$512K	Buy	14,717 +692	+5%	+$24.3K	0.13%	82
2020 Q2	$435K	Sell	14,025 -63	-0.4%	-$2.14K	0.13%	84
2020 Q1	$436K	Sell	14,088 -1,581	-10%	-$53.9K	0.16%	82
2019 Q4	$582K	Sell	15,669 -93	-0.6%	-$3.31K	0.17%	80
2019 Q3	$537K	Sell	15,762 -621	-4%	-$22.6K	0.16%	83
2019 Q2	$673K	Sell	16,383 -185	-1%	-$7.35K	0.21%	75
2019 Q1	$668K	Sell	16,568 -635	-4%	-$25.4K	0.22%	75
2018 Q4	$712K	Sell	17,203 -406	-2%	-$16.9K	0.28%	67
2018 Q3	$736K	Sell	17,609 -385	-2%	-$14.8K	0.23%	80
2018 Q2	$619K	Hold	17,994	–	–	0.22%	80
2018 Q1	$606K	Buy	17,994 +1,387	+8%	+$47.7K	0.22%	83
2017 Q4	$571K	Buy	16,607 +654	+4%	+$22.3K	0.21%	84
2017 Q3	$540K	Sell	15,953 -53	-0.3%	-$1.7K	0.22%	82
2017 Q2	$510K	Hold	16,006	–	–	0.22%	83
2017 Q1	$520K	Buy	16,006 +174	+1%	+$5.49K	0.23%	78
2016 Q4	$488K	Buy	15,832 +416	+3%	+$12.7K	0.24%	80
2016 Q3	$495K	Buy	15,416 +280	+2%	+$9.36K	0.25%	76
2016 Q2	$506K	Buy	15,136 +1,169	+8%	+$37.3K	0.26%	75
2016 Q1	$393K	Buy	13,967 +348	+3%	+$9.94K	0.21%	86
2015 Q4	$417K	Hold	13,619	–	–	0.23%	79
2015 Q3	$406K	Sell	13,619 -43	-0.3%	-$1.38K	0.24%	79
2015 Q2	$435K	Buy	13,662 +43	+0.3%	+$1.4K	0.24%	78
2015 Q1	$450K	Sell	13,619 -1,561	-10%	-$49.6K	0.25%	78
2014 Q4	$449K	Buy	15,180 +2,362	+18%	+$67.7K	0.26%	77
2014 Q3	$360K	Buy	12,818 +432	+3%	+$12.1K	0.23%	81
2014 Q2	$349K	Buy	12,386 +2,769	+29%	+$78.9K	0.22%	78
2014 Q1	$293K	Hold	9,617	–	–	0.2%	86
2013 Q4	$279K	Buy	+9,617	New	+$280K	0.2%	86

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Ascent Wealth Partners's PFE Position: Q1 2026 in Review

Ascent Wealth Partners increased its Pfizer (PFE) stake by 2.8% in Q1 2026, buying an estimated $63.3K and bringing the position to 86,553 shares worth $2.43M. The position accounts for 0.28% of the portfolio, ranked #79.

Ascent Wealth Partners first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Ascent Wealth Partners held 86,553 shares of Pfizer worth $2.43M as of Q1 2026.
Ascent Wealth Partners bought 2,376 Pfizer shares in Q1 2026, an estimated $63.3K.
Pfizer made up 0.28% of Ascent Wealth Partners's portfolio in Q1 2026, its #79 holding.
Ascent Wealth Partners first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Ascent Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.